Phospholipid Transfer Is a Prerequisite for PLTP-Mediated HDL Conversion
Phospholipid transfer protein (PLTP) is an important regulator of high-density lipoprotein (HDL) metabolism. The two main functions of PLTP are transfer of phospholipids between lipoprotein particles and modulation of HDL size and composition in a process called HDL conversion. These PLTP-mediated p...
Gespeichert in:
Veröffentlicht in: | Biochemistry (Easton) 2000-12, Vol.39 (51), p.16092-16098 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 16098 |
---|---|
container_issue | 51 |
container_start_page | 16092 |
container_title | Biochemistry (Easton) |
container_volume | 39 |
creator | Huuskonen, Jarkko Olkkonen, Vesa M Ehnholm, Christian Metso, Jari Julkunen, Ilkka Jauhiainen, Matti |
description | Phospholipid transfer protein (PLTP) is an important regulator of high-density lipoprotein (HDL) metabolism. The two main functions of PLTP are transfer of phospholipids between lipoprotein particles and modulation of HDL size and composition in a process called HDL conversion. These PLTP-mediated processes are physiologically important in the transfer of surface remnants from lipolyzed triglyceride-rich lipoproteins to nascent HDL particles and in the generation of preβ-HDL, the initial acceptor of excess peripheral cell cholesterol. The aim of the study presented here was to investigate the interrelationship between the two functions of PLTP. Plasma PLTP was chemically modified using diethylpyrocarbonate or ethylmercurithiosalicylate. The modified proteins displayed a dose-dependent decrease in phospholipid transfer activity and a parallel decrease in the ability to cause HDL conversion. Two recombinant PLTP mutant proteins, defective in phospholipid transfer activity due to a mutation in the N-terminal lipid-binding pocket, were produced, isolated, and incubated together with radioactively labeled HDL3. HDL conversion was analyzed using three methods: native gradient gel electrophoresis, ultracentrifugation, and crossed immunoelectrophoresis. The results demonstrate that the mutant proteins (i) are able to induce only a modest increase in HDL particle size compared to the wild-type protein, (ii) are unable to release apoA-I from HDL3, and (iii) do not generate preβ-mobile particles following incubation with HDL3. These data suggest that phospholipid transfer is a prerequisite for HDL conversion and demonstrate the close interrelationship between the two main activities of PLTP. |
doi_str_mv | 10.1021/bi0019287 |
format | Article |
fullrecord | <record><control><sourceid>acs_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1021_bi0019287</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>c255582421</sourcerecordid><originalsourceid>FETCH-LOGICAL-a349t-f6885641e0970558c962e7e4590b7fad008953906acc001731aaa6011e6588ec3</originalsourceid><addsrcrecordid>eNptkE1Lw0AQhhdRbK0e_AOSiwcP0dkk-3WU-tFCigHjedkmE7q1TeJuKvrvjaTUi6dhmId3eF5CLincUojo3dICUBVJcUTGlEUQJkqxYzIGAB5GisOInHm_7tcERHJKRpTSKFaxGJNZtmp8u2o2trVlkDtT-wpdMPeBCTKHDj921tsOg6pxQZbmWbjA0poOy2D2kAbTpv5E521Tn5OTymw8XuznhLw9PebTWZi-PM-n92lo4kR1YcWlZDyhCEoAY7JQPEKBCVOwFJUpAaRisQJuiqKXEjE1xnCgFDmTEot4Qm6G3MI13jusdOvs1rhvTUH_tqEPbfTs1cC2u-UWyz9yr98D4QBY3-HX4W7cu-YiFkzn2WsfuqCQSKWnPX898Kbwet3sXN2r_vP4B-Gfchk</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Phospholipid Transfer Is a Prerequisite for PLTP-Mediated HDL Conversion</title><source>MEDLINE</source><source>ACS Publications</source><creator>Huuskonen, Jarkko ; Olkkonen, Vesa M ; Ehnholm, Christian ; Metso, Jari ; Julkunen, Ilkka ; Jauhiainen, Matti</creator><creatorcontrib>Huuskonen, Jarkko ; Olkkonen, Vesa M ; Ehnholm, Christian ; Metso, Jari ; Julkunen, Ilkka ; Jauhiainen, Matti</creatorcontrib><description>Phospholipid transfer protein (PLTP) is an important regulator of high-density lipoprotein (HDL) metabolism. The two main functions of PLTP are transfer of phospholipids between lipoprotein particles and modulation of HDL size and composition in a process called HDL conversion. These PLTP-mediated processes are physiologically important in the transfer of surface remnants from lipolyzed triglyceride-rich lipoproteins to nascent HDL particles and in the generation of preβ-HDL, the initial acceptor of excess peripheral cell cholesterol. The aim of the study presented here was to investigate the interrelationship between the two functions of PLTP. Plasma PLTP was chemically modified using diethylpyrocarbonate or ethylmercurithiosalicylate. The modified proteins displayed a dose-dependent decrease in phospholipid transfer activity and a parallel decrease in the ability to cause HDL conversion. Two recombinant PLTP mutant proteins, defective in phospholipid transfer activity due to a mutation in the N-terminal lipid-binding pocket, were produced, isolated, and incubated together with radioactively labeled HDL3. HDL conversion was analyzed using three methods: native gradient gel electrophoresis, ultracentrifugation, and crossed immunoelectrophoresis. The results demonstrate that the mutant proteins (i) are able to induce only a modest increase in HDL particle size compared to the wild-type protein, (ii) are unable to release apoA-I from HDL3, and (iii) do not generate preβ-mobile particles following incubation with HDL3. These data suggest that phospholipid transfer is a prerequisite for HDL conversion and demonstrate the close interrelationship between the two main activities of PLTP.</description><identifier>ISSN: 0006-2960</identifier><identifier>EISSN: 1520-4995</identifier><identifier>DOI: 10.1021/bi0019287</identifier><identifier>PMID: 11123937</identifier><language>eng</language><publisher>United States: American Chemical Society</publisher><subject>Amino Acid Substitution - genetics ; Apolipoprotein A-I - antagonists & inhibitors ; Apolipoprotein A-I - metabolism ; Biological Transport - drug effects ; Biological Transport - genetics ; Carrier Proteins - antagonists & inhibitors ; Carrier Proteins - chemistry ; Carrier Proteins - genetics ; Carrier Proteins - physiology ; Diethyl Pyrocarbonate - pharmacology ; Dose-Response Relationship, Drug ; Humans ; Lipoproteins, HDL - metabolism ; Membrane Proteins - antagonists & inhibitors ; Membrane Proteins - chemistry ; Membrane Proteins - genetics ; Membrane Proteins - physiology ; Mutagenesis, Site-Directed ; Phospholipid Transfer Proteins ; Phospholipids - antagonists & inhibitors ; Phospholipids - chemistry ; Phospholipids - metabolism ; Recombinant Proteins - chemistry ; Thimerosal - pharmacology</subject><ispartof>Biochemistry (Easton), 2000-12, Vol.39 (51), p.16092-16098</ispartof><rights>Copyright © 2000 American Chemical Society</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a349t-f6885641e0970558c962e7e4590b7fad008953906acc001731aaa6011e6588ec3</citedby><cites>FETCH-LOGICAL-a349t-f6885641e0970558c962e7e4590b7fad008953906acc001731aaa6011e6588ec3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://pubs.acs.org/doi/pdf/10.1021/bi0019287$$EPDF$$P50$$Gacs$$H</linktopdf><linktohtml>$$Uhttps://pubs.acs.org/doi/10.1021/bi0019287$$EHTML$$P50$$Gacs$$H</linktohtml><link.rule.ids>314,780,784,2765,27076,27924,27925,56738,56788</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11123937$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Huuskonen, Jarkko</creatorcontrib><creatorcontrib>Olkkonen, Vesa M</creatorcontrib><creatorcontrib>Ehnholm, Christian</creatorcontrib><creatorcontrib>Metso, Jari</creatorcontrib><creatorcontrib>Julkunen, Ilkka</creatorcontrib><creatorcontrib>Jauhiainen, Matti</creatorcontrib><title>Phospholipid Transfer Is a Prerequisite for PLTP-Mediated HDL Conversion</title><title>Biochemistry (Easton)</title><addtitle>Biochemistry</addtitle><description>Phospholipid transfer protein (PLTP) is an important regulator of high-density lipoprotein (HDL) metabolism. The two main functions of PLTP are transfer of phospholipids between lipoprotein particles and modulation of HDL size and composition in a process called HDL conversion. These PLTP-mediated processes are physiologically important in the transfer of surface remnants from lipolyzed triglyceride-rich lipoproteins to nascent HDL particles and in the generation of preβ-HDL, the initial acceptor of excess peripheral cell cholesterol. The aim of the study presented here was to investigate the interrelationship between the two functions of PLTP. Plasma PLTP was chemically modified using diethylpyrocarbonate or ethylmercurithiosalicylate. The modified proteins displayed a dose-dependent decrease in phospholipid transfer activity and a parallel decrease in the ability to cause HDL conversion. Two recombinant PLTP mutant proteins, defective in phospholipid transfer activity due to a mutation in the N-terminal lipid-binding pocket, were produced, isolated, and incubated together with radioactively labeled HDL3. HDL conversion was analyzed using three methods: native gradient gel electrophoresis, ultracentrifugation, and crossed immunoelectrophoresis. The results demonstrate that the mutant proteins (i) are able to induce only a modest increase in HDL particle size compared to the wild-type protein, (ii) are unable to release apoA-I from HDL3, and (iii) do not generate preβ-mobile particles following incubation with HDL3. These data suggest that phospholipid transfer is a prerequisite for HDL conversion and demonstrate the close interrelationship between the two main activities of PLTP.</description><subject>Amino Acid Substitution - genetics</subject><subject>Apolipoprotein A-I - antagonists & inhibitors</subject><subject>Apolipoprotein A-I - metabolism</subject><subject>Biological Transport - drug effects</subject><subject>Biological Transport - genetics</subject><subject>Carrier Proteins - antagonists & inhibitors</subject><subject>Carrier Proteins - chemistry</subject><subject>Carrier Proteins - genetics</subject><subject>Carrier Proteins - physiology</subject><subject>Diethyl Pyrocarbonate - pharmacology</subject><subject>Dose-Response Relationship, Drug</subject><subject>Humans</subject><subject>Lipoproteins, HDL - metabolism</subject><subject>Membrane Proteins - antagonists & inhibitors</subject><subject>Membrane Proteins - chemistry</subject><subject>Membrane Proteins - genetics</subject><subject>Membrane Proteins - physiology</subject><subject>Mutagenesis, Site-Directed</subject><subject>Phospholipid Transfer Proteins</subject><subject>Phospholipids - antagonists & inhibitors</subject><subject>Phospholipids - chemistry</subject><subject>Phospholipids - metabolism</subject><subject>Recombinant Proteins - chemistry</subject><subject>Thimerosal - pharmacology</subject><issn>0006-2960</issn><issn>1520-4995</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNptkE1Lw0AQhhdRbK0e_AOSiwcP0dkk-3WU-tFCigHjedkmE7q1TeJuKvrvjaTUi6dhmId3eF5CLincUojo3dICUBVJcUTGlEUQJkqxYzIGAB5GisOInHm_7tcERHJKRpTSKFaxGJNZtmp8u2o2trVlkDtT-wpdMPeBCTKHDj921tsOg6pxQZbmWbjA0poOy2D2kAbTpv5E521Tn5OTymw8XuznhLw9PebTWZi-PM-n92lo4kR1YcWlZDyhCEoAY7JQPEKBCVOwFJUpAaRisQJuiqKXEjE1xnCgFDmTEot4Qm6G3MI13jusdOvs1rhvTUH_tqEPbfTs1cC2u-UWyz9yr98D4QBY3-HX4W7cu-YiFkzn2WsfuqCQSKWnPX898Kbwet3sXN2r_vP4B-Gfchk</recordid><startdate>20001226</startdate><enddate>20001226</enddate><creator>Huuskonen, Jarkko</creator><creator>Olkkonen, Vesa M</creator><creator>Ehnholm, Christian</creator><creator>Metso, Jari</creator><creator>Julkunen, Ilkka</creator><creator>Jauhiainen, Matti</creator><general>American Chemical Society</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20001226</creationdate><title>Phospholipid Transfer Is a Prerequisite for PLTP-Mediated HDL Conversion</title><author>Huuskonen, Jarkko ; Olkkonen, Vesa M ; Ehnholm, Christian ; Metso, Jari ; Julkunen, Ilkka ; Jauhiainen, Matti</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a349t-f6885641e0970558c962e7e4590b7fad008953906acc001731aaa6011e6588ec3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><topic>Amino Acid Substitution - genetics</topic><topic>Apolipoprotein A-I - antagonists & inhibitors</topic><topic>Apolipoprotein A-I - metabolism</topic><topic>Biological Transport - drug effects</topic><topic>Biological Transport - genetics</topic><topic>Carrier Proteins - antagonists & inhibitors</topic><topic>Carrier Proteins - chemistry</topic><topic>Carrier Proteins - genetics</topic><topic>Carrier Proteins - physiology</topic><topic>Diethyl Pyrocarbonate - pharmacology</topic><topic>Dose-Response Relationship, Drug</topic><topic>Humans</topic><topic>Lipoproteins, HDL - metabolism</topic><topic>Membrane Proteins - antagonists & inhibitors</topic><topic>Membrane Proteins - chemistry</topic><topic>Membrane Proteins - genetics</topic><topic>Membrane Proteins - physiology</topic><topic>Mutagenesis, Site-Directed</topic><topic>Phospholipid Transfer Proteins</topic><topic>Phospholipids - antagonists & inhibitors</topic><topic>Phospholipids - chemistry</topic><topic>Phospholipids - metabolism</topic><topic>Recombinant Proteins - chemistry</topic><topic>Thimerosal - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Huuskonen, Jarkko</creatorcontrib><creatorcontrib>Olkkonen, Vesa M</creatorcontrib><creatorcontrib>Ehnholm, Christian</creatorcontrib><creatorcontrib>Metso, Jari</creatorcontrib><creatorcontrib>Julkunen, Ilkka</creatorcontrib><creatorcontrib>Jauhiainen, Matti</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Biochemistry (Easton)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Huuskonen, Jarkko</au><au>Olkkonen, Vesa M</au><au>Ehnholm, Christian</au><au>Metso, Jari</au><au>Julkunen, Ilkka</au><au>Jauhiainen, Matti</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Phospholipid Transfer Is a Prerequisite for PLTP-Mediated HDL Conversion</atitle><jtitle>Biochemistry (Easton)</jtitle><addtitle>Biochemistry</addtitle><date>2000-12-26</date><risdate>2000</risdate><volume>39</volume><issue>51</issue><spage>16092</spage><epage>16098</epage><pages>16092-16098</pages><issn>0006-2960</issn><eissn>1520-4995</eissn><abstract>Phospholipid transfer protein (PLTP) is an important regulator of high-density lipoprotein (HDL) metabolism. The two main functions of PLTP are transfer of phospholipids between lipoprotein particles and modulation of HDL size and composition in a process called HDL conversion. These PLTP-mediated processes are physiologically important in the transfer of surface remnants from lipolyzed triglyceride-rich lipoproteins to nascent HDL particles and in the generation of preβ-HDL, the initial acceptor of excess peripheral cell cholesterol. The aim of the study presented here was to investigate the interrelationship between the two functions of PLTP. Plasma PLTP was chemically modified using diethylpyrocarbonate or ethylmercurithiosalicylate. The modified proteins displayed a dose-dependent decrease in phospholipid transfer activity and a parallel decrease in the ability to cause HDL conversion. Two recombinant PLTP mutant proteins, defective in phospholipid transfer activity due to a mutation in the N-terminal lipid-binding pocket, were produced, isolated, and incubated together with radioactively labeled HDL3. HDL conversion was analyzed using three methods: native gradient gel electrophoresis, ultracentrifugation, and crossed immunoelectrophoresis. The results demonstrate that the mutant proteins (i) are able to induce only a modest increase in HDL particle size compared to the wild-type protein, (ii) are unable to release apoA-I from HDL3, and (iii) do not generate preβ-mobile particles following incubation with HDL3. These data suggest that phospholipid transfer is a prerequisite for HDL conversion and demonstrate the close interrelationship between the two main activities of PLTP.</abstract><cop>United States</cop><pub>American Chemical Society</pub><pmid>11123937</pmid><doi>10.1021/bi0019287</doi><tpages>7</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0006-2960 |
ispartof | Biochemistry (Easton), 2000-12, Vol.39 (51), p.16092-16098 |
issn | 0006-2960 1520-4995 |
language | eng |
recordid | cdi_crossref_primary_10_1021_bi0019287 |
source | MEDLINE; ACS Publications |
subjects | Amino Acid Substitution - genetics Apolipoprotein A-I - antagonists & inhibitors Apolipoprotein A-I - metabolism Biological Transport - drug effects Biological Transport - genetics Carrier Proteins - antagonists & inhibitors Carrier Proteins - chemistry Carrier Proteins - genetics Carrier Proteins - physiology Diethyl Pyrocarbonate - pharmacology Dose-Response Relationship, Drug Humans Lipoproteins, HDL - metabolism Membrane Proteins - antagonists & inhibitors Membrane Proteins - chemistry Membrane Proteins - genetics Membrane Proteins - physiology Mutagenesis, Site-Directed Phospholipid Transfer Proteins Phospholipids - antagonists & inhibitors Phospholipids - chemistry Phospholipids - metabolism Recombinant Proteins - chemistry Thimerosal - pharmacology |
title | Phospholipid Transfer Is a Prerequisite for PLTP-Mediated HDL Conversion |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-21T09%3A01%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-acs_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Phospholipid%20Transfer%20Is%20a%20Prerequisite%20for%20PLTP-Mediated%20HDL%20Conversion&rft.jtitle=Biochemistry%20(Easton)&rft.au=Huuskonen,%20Jarkko&rft.date=2000-12-26&rft.volume=39&rft.issue=51&rft.spage=16092&rft.epage=16098&rft.pages=16092-16098&rft.issn=0006-2960&rft.eissn=1520-4995&rft_id=info:doi/10.1021/bi0019287&rft_dat=%3Cacs_cross%3Ec255582421%3C/acs_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/11123937&rfr_iscdi=true |